Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.

Chugh PE, Sin SH, Ozgur S, Henry DH, Menezes P, Griffith J, Eron JJ, Damania B, Dittmer DP.

PLoS Pathog. 2013;9(7):e1003484. doi: 10.1371/journal.ppat.1003484. Epub 2013 Jul 18.

2.

Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.

Haecker I, Gay LA, Yang Y, Hu J, Morse AM, McIntyre LM, Renne R.

PLoS Pathog. 2012;8(8):e1002884. doi: 10.1371/journal.ppat.1002884. Epub 2012 Aug 23. Erratum in: PLoS Pathog. 2013 Mar;9(3). doi: 10.1371/annotation/bb6f7450-8506-41c3-8519-020df8b382b9.

3.

Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.

Paul AG, Chandran B, Sharma-Walia N.

Transl Res. 2013 Aug;162(2):77-92. doi: 10.1016/j.trsl.2013.03.004. Epub 2013 Apr 6. Review.

PMID:
23567332
4.

Proteomic screening of human targets of viral microRNAs reveals functions associated with immune evasion and angiogenesis.

Gallaher AM, Das S, Xiao Z, Andresson T, Kieffer-Kwon P, Happel C, Ziegelbauer J.

PLoS Pathog. 2013;9(9):e1003584. doi: 10.1371/journal.ppat.1003584. Epub 2013 Sep 5.

5.

Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress.

Qin Z, Freitas E, Sullivan R, Mohan S, Bacelieri R, Branch D, Romano M, Kearney P, Oates J, Plaisance K, Renne R, Kaleeba J, Parsons C.

PLoS Pathog. 2010 Jan 29;6(1):e1000742. doi: 10.1371/journal.ppat.1000742.

6.

Modulation of B-cell exosome proteins by gamma herpesvirus infection.

Meckes DG Jr, Gunawardena HP, Dekroon RM, Heaton PR, Edwards RH, Ozgur S, Griffith JD, Damania B, Raab-Traub N.

Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2925-33. doi: 10.1073/pnas.1303906110. Epub 2013 Jul 1.

7.

Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.

An FQ, Folarin HM, Compitello N, Roth J, Gerson SL, McCrae KR, Fakhari FD, Dittmer DP, Renne R.

J Virol. 2006 May;80(10):4833-46.

8.

The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility.

Wu YH, Hu TF, Chen YC, Tsai YN, Tsai YH, Cheng CC, Wang HW.

Blood. 2011 Sep 8;118(10):2896-905. doi: 10.1182/blood-2011-01-330589. Epub 2011 Jun 28.

9.

Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology.

McAllister SC, Moses AV.

Curr Top Microbiol Immunol. 2007;312:211-44. Review.

PMID:
17089799
10.

Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.

Ramalingam D, Happel C, Ziegelbauer JM.

J Virol. 2015 Apr;89(8):4249-61. doi: 10.1128/JVI.03687-14. Epub 2015 Jan 28.

11.

Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.

Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR.

Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5570-5. Epub 2005 Mar 30.

12.

Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.

Yan Q, Ma X, Shen C, Cao X, Feng N, Qin D, Zeng Y, Zhu J, Gao SJ, Lu C.

J Virol. 2014 May;88(9):4987-5000. doi: 10.1128/JVI.00025-14. Epub 2014 Feb 19.

13.

Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells.

Yogev O, Lagos D, Enver T, Boshoff C.

PLoS Pathog. 2014 Sep 25;10(9):e1004400. doi: 10.1371/journal.ppat.1004400. eCollection 2014 Sep.

14.

Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells.

Viollet C, Davis DA, Reczko M, Ziegelbauer JM, Pezzella F, Ragoussis J, Yarchoan R.

PLoS One. 2015 May 5;10(5):e0126439. doi: 10.1371/journal.pone.0126439. eCollection 2015.

15.

Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes.

Singh VV, Kerur N, Bottero V, Dutta S, Chakraborty S, Ansari MA, Paudel N, Chikoti L, Chandran B.

J Virol. 2013 Apr;87(8):4417-31. doi: 10.1128/JVI.03282-12. Epub 2013 Feb 6.

16.

Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling.

Choi HS, Jain V, Krueger B, Marshall V, Kim CH, Shisler JL, Whitby D, Renne R.

PLoS Pathog. 2015 Nov 6;11(11):e1005255. doi: 10.1371/journal.ppat.1005255. eCollection 2015.

17.

Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells.

Vart RJ, Nikitenko LL, Lagos D, Trotter MW, Cannon M, Bourboulia D, Gratrix F, Takeuchi Y, Boshoff C.

Cancer Res. 2007 May 1;67(9):4042-51.

18.

Modulation of Kaposi's sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1.

Giffin L, Yan F, Ben Major M, Damania B.

J Virol. 2014 Aug;88(16):9429-41. doi: 10.1128/JVI.00511-14. Epub 2014 Jun 11. Erratum in: J Virol. 2014 Nov;88(21):12932.

19.

Cellular microRNAs 498 and 320d regulate herpes simplex virus 1 induction of Kaposi's sarcoma-associated herpesvirus lytic replication by targeting RTA.

Yan Q, Li W, Tang Q, Yao S, Lv Z, Feng N, Ma X, Bai Z, Zeng Y, Qin D, Lu C.

PLoS One. 2013;8(2):e55832. doi: 10.1371/journal.pone.0055832. Epub 2013 Feb 13.

20.

Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines.

Gottwein E, Corcoran DL, Mukherjee N, Skalsky RL, Hafner M, Nusbaum JD, Shamulailatpam P, Love CL, Dave SS, Tuschl T, Ohler U, Cullen BR.

Cell Host Microbe. 2011 Nov 17;10(5):515-26. doi: 10.1016/j.chom.2011.09.012.

Items per page

Supplemental Content

Write to the Help Desk